Our Technology
At Panama Fertility, our laboratory is equipped with advanced technology used in leading fertility centers around the world. Every investment we make is focused on one goal: giving your embryos the most stable, precise, and carefully monitored environment possible.
Experts in embryo ai
MIRI® TL Time Lapse Incubator
The MIRI® TL Time-Lapse system allows continuous monitoring of embryo development without removing them from their controlled environment, ensuring maximum stability and optimal conditions at every stage.
Each patient’s embryos are kept in individually monitored chambers with dedicated imaging, eliminating the risk of cross-contamination while maintaining precise control of temperature, CO₂, and O₂ levels.
By capturing thousands of images throughout development, the system creates a complete visual record from fertilization to transfer, enabling our embryology team to make more informed and precise decisions.
CONTINUOUS MONITORING
Embryos remain undisturbed in a stable environment throughout their development.
INDIVIDUAL CHAMBERS
Each embryo is monitored separately, ensuring higher safety and controlled conditions.
THOUSANDS OF IMAGES
A complete visual record is created from fertilization to embryo transfer.
VIDEO DEVELOPMENT TRACKING
Embryologists can review every stage of development in detail for better decision-making.
PATIENT ACCESS
Patients can follow embryo development through a secure digital platform, offering transparency and peace of mind.
advanced artificial intelligence
Chloe AI - FDA-Cleared Embryo Assessment
Chloe AI is an advanced artificial intelligence platform designed to support embryo selection with greater precision.
It is the first and only AI with FDA (510k) clearance for embryo assessment, combining time-lapse imaging with data-driven analysis to identify patterns that may not be visible through traditional observation.
By integrating clinical data with expert evaluation, Chloe AI helps improve accuracy, confidence, and decision-making throughout the process.
FDA-CLEARED TECHNOLOGY
The first AI with FDA (510k) clearance for embryo assessment, approved in 2025.
HIGH ACCURACY
Up to 96% accuracy in blastocyst prediction and 73% in implantation potential.
BETTER OUTCOMES
Associated with a 23% increase in ongoing pregnancy rates and a 36% reduction in early pregnancy loss.
OBJECTIVE ANALYSIS
Uses morphokinetic data to evaluate embryo development beyond traditional visual assessment.
SMART DECISION SUPPORT
Helps identify the embryo with the highest potential for a successful pregnancy.